Metraipolis › archive › dc_3a8726ab76cc
Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41142791
- DOI
- 10.3389/fimmu.2025.1618118
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:53:39.004Z
- SHA-256 of the archived text
5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3- Stable URL of this page
https://metraipolis.com/documento/dc_3a8726ab76cc
How to cite
Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791 — Europe PMC (en), https://europepmc.org/article/MED/41142791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3a8726ab76cc (Metraipolis archive dc_3a8726ab76cc, sha256 5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3)
BibTeX
@misc{dc3a8726ab76cc,
title = {Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker — Europe PMC PMID:41142791},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41142791},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3a8726ab76cc; sha256 5f9da950afce4b3386b1b9a92ff15ca41c08d01355ba4248a7a0f59dbb10bfc3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41142791. Agents can read the archived copy with the MCP tool read_document.